Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Decabromodiphenyl Ethane Sensitizes Zebrafish to Alcoholic Liver Injury by Compromising NAD+-Mediated Multicellular Responses.

Created on 11 Aug 2026

Authors

Fan Li, Lihua Yang, Yindan Zhang, Kaiyu Fu, Yuxi Zhou, Yanna Han, Wei Zhang, Jian Han, Bingsheng Zhou

Published in

Environmental science & technology. Volume 60. Issue 31. Pages 21569-21581. Aug 11, 2026.

Abstract

Epidemiological evidence has confirmed an association between environmental contaminants and elevated risk of liver injury in alcohol consumers. Decabromodiphenyl ethane (DBDPE) is a novel brominated flame retardant that can accumulate in the liver. Given the widespread environmental distribution of DBDPE and rising burden of alcohol abuse, this study investigated the impact of DBDPE on alcoholic liver injury progression by preexposing male zebrafish to DBDPE followed by an acute ethanol challenge. The results showed that DBDPE induced tissue damage and lipid accumulation, which correlated with mitochondrial dysfunction and oxidative stress. DBDPE pre-exposure significantly impaired recovery from ethanol-induced liver injury, as evidenced by delayed normalization of serum transaminase activities. Single-cell transcriptomics further revealed that DBDPE disrupted the tight junction pathway in cholangiocytes and suppressed alcohol metabolism-related pathways in hepatocytes, which correlated with subsequent cholestasis and impaired liver recovery after alcohol challenge. Notably, these adverse effects were driven by NAD+ deficiency, as supplementation with nicotinamide riboside to restore NAD+ levels effectively mitigated DBDPE-induced impairments. Our findings suggest that DBDPE increases zebrafish susceptibility to and impedes recovery from alcoholic liver injury through NAD+ suppression, identifying it as an environmental risk factor for the progression of alcoholic liver disease.

PMID:
42579127
Bibliographic data and abstract were imported from PubMed on 11 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement